Cargando…
Experimental Drugs for Chemotherapy- and Cancer-Related Anemia
Anemia in cancer patients is a relevant condition complicating the course of the neoplastic disease. Overall, we distinguish the anemia which arises under chemotherapy as pure adverse event of the toxic effects of the drugs used, and the anemia induced by the tumour-associated inflammation, oxidativ...
Autores principales: | Madeddu, Clelia, Neri, Manuela, Sanna, Elisabetta, Oppi, Sara, Macciò, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238072/ https://www.ncbi.nlm.nih.gov/pubmed/34194245 http://dx.doi.org/10.2147/JEP.S262349 |
Ejemplares similares
-
Cachexia as Evidence of the Mechanisms of Resistance and Tolerance during the Evolution of Cancer Disease
por: Maccio, Antonio, et al.
Publicado: (2021) -
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
por: Macciò, Antonio, et al.
Publicado: (2021) -
Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer
por: Sanna, Elisabetta, et al.
Publicado: (2021) -
Diagnostic Framework of Pelvic Massive Necrosis with Peritonitis following Chemoradiation for Locally Advanced Cervical Cancer: When Is the Surgery Not Demandable? A Case Report and Literature Review
por: Sanna, Elisabetta, et al.
Publicado: (2022) -
Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report
por: Madeddu, Clelia, et al.
Publicado: (2022)